Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00448448 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)

Study acronym: BrAIST
StatusTerminated
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Publications: 6 to 11v28 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  2. Lead sponsor: Stuart Weinstein to Stuart L. Weinstein, MD Publications: 5 to 6v27 Show all 2 changesShow less
    • Publications: 5 to 6

    See this version in full on ClinicalTrials.gov ↗

  3. Publications: 4 to 5v26 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  4. Phase: Phase 3 to Not applicable Lead sponsor: University of Iowa to Stuart Weinstein · Trial status: Completed to Terminated · Sponsor's reason: Stopped for efficacy · 2 morev25 Show all 6 changesShow less
    • Lead sponsor: University of Iowa to Stuart Weinstein
    • Trial status: Completed to Terminated
    • Sponsor's reason: Stopped for efficacy
    • Secondary endpoints shortened, about 6 words
    • Publications: 2 to 4

    See this version in full on ClinicalTrials.gov ↗

  5. Results first posted: Jul 23, 2014 Primary endpoints: 2 to 1 · Trial status: Active, Not Recruiting to Completed · Enrollment target: estimated 500 to confirmed 383 · 3 morev24 Show all 7 changesShow less
    • Primary endpoints: 2 to 1
    • Trial status: Active, Not Recruiting to Completed
    • Enrollment target: estimated 500 to confirmed 383
    • Primary and study completion dates changed from estimate of Aug 2014 to Sep 2013
    • Secondary endpoints revised (3)
    • Publications: 1 to 2

    See this version in full on ClinicalTrials.gov ↗

Show 22 earlier versionsHide 22 earlier versions
  1. Primary and study completion dates: Aug 2012 to Aug 2014 Interventions: Brace (Device), Watchful waiting (Other) to Brace (Device), Observation (Other)v23 Show all 2 changesShow less
    • Interventions: Brace (Device), Watchful waiting (Other) to Brace (Device), Observation (Other)
  2. Trial status: Recruiting to Active, Not Recruiting Site details revised at 25 of 25 sitesv22 Show all 2 changesShow less
    • Site details revised at 25 of 25 sites
  3. Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to University of Iowa Primary and study completion dates: Aug 2010 to Aug 2012 · Study sites: 26 to 25 · Collaborators revised (5) · 1 morev21 Show all 5 changesShow less
    • Primary and study completion dates: Aug 2010 to Aug 2012
    • Study sites: 26 to 25
    • Collaborators revised (5)
    • Study description expanded, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  4. Site contacts updated at 9 of 26 sitesv20
  5. 2 versions Re-verified since Mar 31, 2009, no change to tracked fieldsv18-v19
  6. Study sites: 25 to 26 Eligibility criteria revisedv17 Show all 2 changesShow less
    • Eligibility criteria revised

    See this version in full on ClinicalTrials.gov ↗

  7. Study sites: 24 to 25 Collaborators: 4 to 5v16 Show all 2 changesShow less
    • Collaborators: 4 to 5

    See this version in full on ClinicalTrials.gov ↗

  8. Study sites: 23 to 24v15
  9. Study sites: 20 to 23v14
  10. Study sites: 21 to 20 Collaborators: 3 to 4v13 Show all 2 changesShow less
    • Collaborators: 3 to 4

    See this version in full on ClinicalTrials.gov ↗

  11. Primary completion date: Aug 2010v12
  12. Site contacts updated at 6 of 21 sitesv11
  13. Study title shortened, about 4 wordsv10 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  14. Interventions: Brace (Device) to Brace (Device), Watchful waiting (Other) Eligibility criteria shortened, about 24 words · Secondary endpoints revised (3) · Study description shortened, about 11 words · 3 morev9 Show all 7 changesShow less
    • Eligibility criteria shortened, about 24 words
    • Secondary endpoints revised (3)
    • Study description shortened, about 11 words
    • Study sites revised (21)
    • Study arms: 0 to 2
    • Study title expanded, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  15. Lead sponsor: University of Iowa to National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Collaborators revised (3)v8 Show all 2 changesShow less
    • Collaborators revised (3)

    See this version in full on ClinicalTrials.gov ↗

  16. Study sites: 16 to 21v7
  17. Site details revised at 5 of 16 sitesv6
  18. Site details revised at 1 of 16 sitesv5
  19. Site details revised at 1 of 16 sitesv4
  20. Site details revised at 1 of 16 sitesv3
  21. Site contacts updated at 1 of 16 sitesv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Adolescent idiopathic scoliosis (AIS) is a structural curve of the spine with no clear underlying cause. Bracing is currently the standard of care for preventing curve progression and treating AIS. However, the effectiveness of bracing remains unclear. The purpose of this study is to compare the risk of curve progression in adolescents with AIS who wear a brace versus those who do not and to determine whether there are reliable factors that can predict the usefulness of bracing for a particular individual with AIS.
Trial Details
NCT Number NCT00448448
Lead Sponsor Stuart L. Weinstein, MD
Collaborators: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Canadian Institutes of Health Research (CIHR), Shriners Hospitals for Children, Children's Mercy Hospital Kansas City, University of Rochester
Conditions Adolescent Idiopathic Scoliosis
Enrollment 383 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov